Skip to content
☰ Menu
Preprint · CC0 via OpenAlex

Urolithin A as a gut microbiota-derived mitophagy activator: a systematic review of mechanisms, preclinical evidence, and human trials

Mohamed E. El‐Beeh

· 2026

Dysbiosis Disabled macroautophagy Human Systematic review Preclinical / animal Review
＋ Sign in to save

Abstract

Retrospective registration of a completed PRISMA 2020 systematic review of urolithin A (mitophagy activation, muscle and immune ageing, safety/pharmacokinetics, metabotypes, and preclinical efficacy). Data extraction was complete at the time of registration; this is a transparent retrospective record. Authors: Alaa Talal Qumsani; Mohamed E. Elbeeh (Umm Al-Qura University).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.17605/osf.io/qx456
Canonical
link ↗
Fetched
2026-10-12 MST

Cite this

APA
El‐Beeh, M.E. (2026). Urolithin A as a gut microbiota-derived mitophagy activator: a systematic review of mechanisms, preclinical evidence, and human trials. https://doi.org/10.17605/osf.io/qx456
Vancouver
El‐Beeh ME. Urolithin A as a gut microbiota-derived mitophagy activator: a systematic review of mechanisms, preclinical evidence, and human trials. 2026. doi:10.17605/osf.io/qx456.
BibTeX
@unpublished{mohamed2026Urolit, title = {Urolithin A as a gut microbiota-derived mitophagy activator: a systematic review of mechanisms, preclinical evidence, and human trials}, author = {Mohamed E. El‐Beeh}, year = {2026}, doi = {10.17605/osf.io/qx456}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings